RNDr. Andrea Blahová, Nikola Chovanová, Kristína Lengyelová, MUDr. Lenka Oravcová, Kristína Juríková, Mgr. Jakub Petrík, Michaela Patáková-Zrubcová, RNDr. Renáta Lukačková
The myelodysplastic syndrome (MDS) is a heterogeneous group of clonal haematopoietic disorders originated in the bone marrow. It is characterized by ineffective haematopoiesis, dysplastic changes...
Molecular analysis of prognostically significant markers of chronic lymphocytic leukemia
Mgr. Erika Tomková, RNDr. Miroslav Tomka, PhD., RNDr. Renáta Lukačková, Mgr. Jakub Petrík
Chronic lymphocytic leukemia (CLL) is a clinically and biologically substantially heterogenous disease. In general, patients are classified into two groups: patients with indolent disease form...
Cytogenetic and molecular changes in myelodysplastic syndromes
RNDr. Renáta Lukačková, Mgr. Jakub Petrík, Mgr. Kristína Juríková
Myelodysplastic syndromes (MDS) consist of hematologic diseases which differ in clinical features and also in cytogenetic presentation. They are characterized with abnormal development of at...
